Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

UAE-based healthtech BioSapien has raised $5.5 million pre-Series A fundraise, led by Global Ventures with participation from ...

Local car magnate and philanthropist Herb Chambers has made a $100 million donation to one of Boston’s largest hospitals with the hope of finding a cure for cancer. The donation to Massachusetts ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...

CATALIST-LISTED Singapore Institute of Advanced Medicine (SAM) has set up a strategic review committee that will look into ...